Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma included in S&P Global Sustainability Yearbook 2024

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Our Managing Director, Dilip Shanghvi, penned an article for the @EconomicTimes on the interim Union Budget, where he shared his views on how he sees the budget steering India towards a future of comprehensive and sustainable growth.

Read it here: https://bit.ly/3SlBKZr

Our teams embrace the joy of being Great Place to Work® Certified™ in 25 countries. Together, we shine brightest!

#GPTWCertified #WeAreSun #TeamSunPharma

Our Managing Director, Dilip Shanghvi, provides an overview of our Q3 FY24 results.
Read more: https://bit.ly/4blT4Gy

#QuarterlyUpdate #Q3Results #SunPharma

We have announced our Q3 FY24 results.
Read more: https://bit.ly/4blT4Gy

#ReachingPeopleTouchingLives #Q3Results #SunPharma

As we celebrate Sun being Great Place to Work Certified in 25 countries, our MD, Dilip Shanghvi shares his reflections on the significance this holds for the team.

#GPTWCertified #WeAreSun

Our Canadian colleagues exuded enthusiasm as they came together to celebrate 40 years of Sun Pharma. The atmosphere was brimming with contagious smiles, pride, and the joy of indulging in delightful cake!

#40UnderTheSun #WeAreSun #SunPharma

In 2013, a moment of great pride unfolded as we successfully introduced the first affordable generic medicine for Ovarian cancer, DOXOrubicin Hydrochloride, in USA.

#40UnderTheSun #ReachingPeopleTouchingLives #WeAreSun

Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top